维普中文期刊产品整合服务
39篇 您的检索式:作者名="Erben P"
    题名 作者 年代 出处 被引量
1KRAS and BRAF muta-tions and PTEN expression do not predict efficacy of cetuximab-basedchemoradiotherapy in locally advanced rectal cancer显示文摘Erben P StrSbel P Horisberger K 2011Int J Radi-at Oncol Biol Phys2011,81,4:1
2Harmonization of molecular monitoring of CML therapy in Europe显示文摘Müller MC Cross NC Erben P 0,,11:1
3Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis显示文摘Erben P Gosenca D Muller MC 2010Haematologica2010,95,5:1
4KRAS and BRAF mutation and PETEN expression do not predict efficacy of cetuxiamb-based chemoradiotherapy in locally advanced rectal cancer显示文摘Erben P Storbel P Horisberger K 2011Int J Radiat Oncol Biol Phys2011,81,4:1
5Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome:a phase-Ⅱ study显示文摘Metzgeroth G Walz C Erben P 0,,05:1
6Harmonization of molecu-lar monitoring of CML therapy in Europe 显示文摘Muller MC Cross NC Erben P 2009Leukemia2009,23,11:1
7Stability of conversionfactors for BCR-ABL monitoring-implications for the frequencyof validation rounds 显示文摘Muller MC Munjal U Erben P 2010Blood (ASH Annual MeetingAbstracts)2010,116,:1
8Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome:a phase-II study显示文摘Metzgeroth G Walz C Erben P 2008Br J Haematol2008,143,5:1
9Chemotherapeutic alteration of VEGF-/PDGF-and PDGF-Ralpha/beta expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro显示文摘Schultz JD Muhlheim K Erben P 2011Oncol Rep2011,26,:1
10Dynamics of BCRABL mutated clones prior to hematologic or cytogenetic resistance to imatinib 显示文摘Ernst T Erben P Muller MC 2008Haematologiea2008,93,2:1
11Safety and efficacy of imatinib in chronic eosinophilic leukaemia and hypereosinophilic syndrome:a phase-Ⅱ study显示文摘Metzgeroth G Walz C Erben P 2008Br J Haematol2008,143,:1
12Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinib 显示文摘Ernst T Erben P Muller MC 2008Haematologica2008,93,2:1
13Acoustic energy: a new transfection method for cancer of the prostate, cancer of the bladder and benign kidney cells显示文摘Michel MS Erben P Trojan L 2004Anticancer Res2004,24,4:1
14Annexin and survivinin locally advanced rectal cancer:indicators of resistance topreoperative chemoradiotherapy显示文摘Horisberger K Erben P Strbel P 2010Onkologie2010,33,89:1
15Assessment of the outcomes of health intervention显示文摘Erben R Franzkowiak P Wenzel E 1992Social Science Medicine1992,35,:1
16Annexin and survivin in locally advanced rectal cancer: indicators of resistance to preoperative chemoradiotherapy? 显示文摘Horisberger K Erben P Strbel P 2010Onkologie2010,33,89:1
17KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancer显示文摘Erben P StrObel P Horisberger K 2011Int J Radiat Oncol Biol Phys2011,81,4:1
18Chemotherapeutic altera?tion of VEGF-/PDGF-and PDGF-Ra/j3 expression by imatinib in HPV - transformed squamous cell carcinoma compared to HPV - nega?tive HNSCC in vitro显示文摘SchultzJD Muhlheim K Erben P 2011Oncol Rep2011,26,5:1
19Long-term Fgf23 deficiency does not influence aging,glucose homeostasis,or fat metabolism in mice with a nonfunctioning vitamin D receptor显示文摘Streicher C Z eitz U A ndrukhova O R upprecht A P ohl E Larsson TE Windisch W Lanske B Erben RG 0,,:1
20Treatment of nutcracker syn- drome with open and endovascular interventions显示文摘Erben Y Gloviczki P Kalra M 2015J Vasc Surg Ve- nous Lymphat Disord2015,3,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费